Recombinant multi-species DSS1/SEM1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine DSS1/SEM1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The product of this gene has been localized within the split hand/split foot malformation locus SHFM1 at chromosome 7. It has been proposed to be a candidate gene for the autosomal dominant form of the heterogeneous limb developmental disorder split hand/split foot malformation type 1. In addition, it has been shown to directly interact with BRCA2. It also may play a role in the completion of the cell cycle. [provided by RefSeq, Jul 2008]
The Alternative Names of target: 26S proteasome complex subunit DSS1,26S proteasome complex subunit SEM1,C7orf76,DSS1,Deleted in split hand/split foot protein 1,Dss1,ECD,PSMD15,SEM1,SHFD1,SHFM1,SHSF1,Sem1,Shfdg1,Shfg,Shfm1,Split hand/foot deleted protein 1,Split hand/foot malformation type 1 protein

Target products collectionGo to DSS1/SEM1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP12284-Ag-1/ GM-Tg-hg-IP12284-Ag-2 Human DSS1/SEM1 protein Human
GM-Tg-rg-IP12284-Ag-1/ GM-Tg-rg-IP12284-Ag-2 Rat DSS1/SEM1 protein Rat
GM-Tg-mg-IP12284-Ag-1/ GM-Tg-mg-IP12284-Ag-2 Mouse DSS1/SEM1 protein Mouse
GM-Tg-cynog-IP12284-Ag-1/ GM-Tg-cynog-IP12284-Ag-2 Cynomolgus/Rhesus macaque DSS1/SEM1 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP12284-Ag-1/ GM-Tg-felg-IP12284-Ag-2 Feline DSS1/SEM1 protein Feline
GM-Tg-cang-IP12284-Ag-1/ GM-Tg-cang-IP12284-Ag-2 Canine DSS1/SEM1 protein Canine
GM-Tg-bovg-IP12284-Ag-1/ GM-Tg-bovg-IP12284-Ag-2 Bovine DSS1/SEM1 protein Bovine
GM-Tg-equg-IP12284-Ag-1/ GM-Tg-equg-IP12284-Ag-2 Equine DSS1/SEM1 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP12284-Ag-1/ GM-Tg-hg-IP12284-Ag-2; GM-Tg-rg-IP12284-Ag-1/ GM-Tg-rg-IP12284-Ag-2;
GM-Tg-mg-IP12284-Ag-1/ GM-Tg-mg-IP12284-Ag-2; GM-Tg-cynog-IP12284-Ag-1/ GM-Tg-cynog-IP12284-Ag-2;
GM-Tg-felg-IP12284-Ag-1/ GM-Tg-felg-IP12284-Ag-2; GM-Tg-cang-IP12284-Ag-1/ GM-Tg-cang-IP12284-Ag-2;
GM-Tg-bovg-IP12284-Ag-1/ GM-Tg-bovg-IP12284-Ag-2; GM-Tg-equg-IP12284-Ag-1/ GM-Tg-equg-IP12284-Ag-2
Products Name DSS1/SEM1 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name DSS1/SEM1
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine DSS1/SEM1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.